Atrial fibrillation prevalence, awareness and management in a nationwide survey of adults in China

Abstract

ObjectiveTo determine AF prevalence and gaps in atrial fibrillation (AF) awareness and management in China.MethodsWe conducted a community-based survey of 47 841 adults (age ≥45 years) in seven geographic regions of China between 2014 and 2016. Participants underwent a structured questionnaire, a standard 12-lead ECG, physical examination and blood sampling. AF prevalence, defined by either ECG detection or self-report, was estimated according to sampling weights, non-response and age and sex distribution of the population. We used multivariable logistic regression to estimate associations among sociodemographic, clinical and geographic factors with the AF prevalence, awareness and treatment.ResultsThe weighted AF prevalence was 1.8% (95% CI 1.7% to 1.9%), but varied from 0.9% to 2.4% across geographical regions and equates to being present in an estimated 7.9 (95% CI 7.4 to 8.4) million people in China. Among men and women, the AF prevalence increased from 0.8% and 0.6% in the age group 45–54 years to 5.4% and 4.9% in the age group ≥75 years, respectively. Proportions of people who were aware of having AF decreased overall from 65.3% in 45–54 year-olds to 53.9% in ≥75 year-olds and varied between sex (men 58.5%, women 68.8%) and residency status (urban 78.3%, rural 35.3%). Only 6.0% of patients with high-risk AF received anticoagulation therapy.ConclusionsAF prevalence is higher than previously reported in China, with low awareness and large treatment gaps. Large-scale efforts are urgently needed to reduce AF adverse consequences.

Assessment of Trends in Guideline-Based Oral Anticoagulant Prescription for Patients With Ischemic Stroke and Atrial Fibrillation in China

“…However, only 6.0% of patients with high-risk AF received anticoagulation therapy. 31 Therefore, more efforts at the community level are needed for stroke prevention. Considerable efforts were made to improve adherence to evidence-based performance measures among patients with acute ischemic stroke in China.…”

Integrated Care of Atrial Fibrillation Using the ABC (Atrial fibrillation Better Care) Pathway Improves Clinical Outcomes in Chinese Population: An Analysis From the Chinese Atrial Fibrillation Registry

“…In China, nearly 7.9 million (about 2%) people suffer from atrial fibrillation ( 15 ). In addition, the anticoagulated rate and comorbidities control rate are quite low (6 and 4% respectively) ( 15 , 16 ), thus comprehensive management seems to be urgent for Chinese population. However, the beneficial evidence of this kind of pathway remains limited in Chinese population.…”

Elevated Peripheral T Helper Cells Are Associated With Atrial Fibrillation in Patients With Rheumatoid Arthritis

“…In 2010, AF was the most common type of arrhythmia (estimated lifetime risk of 22%-26%), as it affected ~33.5 million individuals worldwide (7). More recently, a large national survey revealed that ~7.9 million people suffer from AF in China (8). AF is associated with substantial morbidity, reduced quality of life (QOL), and increased mortality due to the combination of altered hemodynamics, progressive atrial and ventricular mechanical dysfunction, heart failure, and thromboembolic complications; thus, AF is a major burden on the healthcare systems.…”